FDA approves new daily Wegovy pill — and it’ll be available way sooner than you think
The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment cleared for use without injections. “As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy … Read more